Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 212

1.

Role and prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand death receptor DR5 in nonsmall-cell lung cancer and precursor lesions.

Cooper WA, Kohonen-Corish MR, Zhuang L, McCaughan B, Kennedy C, Screaton G, Sutherland RL, Lee CS.

Cancer. 2008 Jul 1;113(1):135-42. doi: 10.1002/cncr.23528.

PMID:
18457325
[PubMed - indexed for MEDLINE]
Free Article
2.

Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer.

Cooper WA, Kohonen-Corish MR, McCaughan B, Kennedy C, Sutherland RL, Lee CS.

Histopathology. 2009 Jul;55(1):28-36. doi: 10.1111/j.1365-2559.2009.03331.x.

PMID:
19614764
[PubMed - indexed for MEDLINE]
3.

Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy.

Leithner K, Stacher E, Wurm R, Ploner F, Quehenberger F, Wohlkoenig C, Bálint Z, Polachova J, Olschewski A, Samonigg H, Popper HH, Olschewski H.

Lung Cancer. 2009 Jul;65(1):98-104. doi: 10.1016/j.lungcan.2008.10.015. Epub 2008 Dec 9.

PMID:
19081160
[PubMed - indexed for MEDLINE]
4.

Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors.

Spierings DC, de Vries EG, Timens W, Groen HJ, Boezen HM, de Jong S.

Clin Cancer Res. 2003 Aug 15;9(9):3397-405.

PMID:
12960128
[PubMed - indexed for MEDLINE]
Free Article
5.

Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.

Zhang Z, Ma J, Li N, Sun N, Wang C.

Ann Thorac Surg. 2006 Jul;82(1):243-8.

PMID:
16798222
[PubMed - indexed for MEDLINE]
6.

Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.

Liao WT, Wang X, Xu LH, Kong QL, Yu CP, Li MZ, Shi L, Zeng MS, Song LB.

Cancer. 2009 Apr 1;115(7):1507-17. doi: 10.1002/cncr.24128.

PMID:
19170237
[PubMed - indexed for MEDLINE]
Free Article
7.

Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.

van Geelen CM, Westra JL, de Vries EG, Boersma-van Ek W, Zwart N, Hollema H, Boezen HM, Mulder NH, Plukker JT, de Jong S, Kleibeuker JH, Koornstra JJ.

J Clin Oncol. 2006 Nov 1;24(31):4998-5004.

PMID:
17075118
[PubMed - indexed for MEDLINE]
8.

Prognostic significance of tumor necrosis factors and their receptors in nonsmall cell lung carcinoma.

Tran TA, Kallakury BV, Ambros RA, Ross JS.

Cancer. 1998 Jul 15;83(2):276-82.

PMID:
9669810
[PubMed - indexed for MEDLINE]
9.

KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factor: an immunohistochemical analysis.

Higashiyama M, Kodama K, Yokouchi H, Takami K, Adachi M, Taki T, Ishiguro S, Nakamori S, Yoshie O, Miyake M.

Cancer. 1998 Aug 1;83(3):466-74.

PMID:
9690539
[PubMed - indexed for MEDLINE]
10.

PED is overexpressed and mediates TRAIL resistance in human non-small cell lung cancer.

Zanca C, Garofalo M, Quintavalle C, Romano G, Acunzo M, Ragno P, Montuori N, Incoronato M, Tornillo L, Baumhoer D, Briguori C, Terracciano L, Condorelli G.

J Cell Mol Med. 2008 Dec;12(6A):2416-26. doi: 10.1111/j.1582-4934.2008.00283.x. Epub 2008 Feb 15.

PMID:
18284607
[PubMed - indexed for MEDLINE]
11.

TRAIL-R2 is not correlated with p53 status and is rarely mutated in non-small cell lung cancer.

Wu WG, Soria JC, Wang L, Kemp BL, Mao L.

Anticancer Res. 2000 Nov-Dec;20(6B):4525-9.

PMID:
11205299
[PubMed - indexed for MEDLINE]
12.

Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells.

Chen W, Wang X, Zhuang J, Zhang L, Lin Y.

Carcinogenesis. 2007 Oct;28(10):2114-21. Epub 2007 Jun 4.

PMID:
17548900
[PubMed - indexed for MEDLINE]
Free Article
13.

Prognostic significance of anti-apoptosis proteins survivin and bcl-2 in non-small cell lung carcinomas: a clinicopathologic study of 102 cases.

Kren L, Brazdil J, Hermanova M, Goncharuk VN, Kallakury BV, Kaur P, Ross JS.

Appl Immunohistochem Mol Morphol. 2004 Mar;12(1):44-9. Review.

PMID:
15163019
[PubMed - indexed for MEDLINE]
14.

Progression in melanoma is associated with decreased expression of death receptors for tumor necrosis factor-related apoptosis-inducing ligand.

Zhuang L, Lee CS, Scolyer RA, McCarthy SW, Zhang XD, Thompson JF, Screaton G, Hersey P.

Hum Pathol. 2006 Oct;37(10):1286-94. Epub 2006 Jul 18.

PMID:
16949935
[PubMed - indexed for MEDLINE]
15.

Versican in nonsmall cell lung cancer: relation to hyaluronan, clinicopathologic factors, and prognosis.

Pirinen R, Leinonen T, Böhm J, Johansson R, Ropponen K, Kumpulainen E, Kosma VM.

Hum Pathol. 2005 Jan;36(1):44-50.

PMID:
15712181
[PubMed - indexed for MEDLINE]
16.

WWOX expression in different histologic types and subtypes of non-small cell lung cancer.

Donati V, Fontanini G, Dell'Omodarme M, Prati MC, Nuti S, Lucchi M, Mussi A, Fabbri M, Basolo F, Croce CM, Aqeilan RI.

Clin Cancer Res. 2007 Feb 1;13(3):884-91.

PMID:
17289881
[PubMed - indexed for MEDLINE]
Free Article
17.

Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.

De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.

Lung Cancer. 2009 Mar;63(3):410-7. doi: 10.1016/j.lungcan.2008.06.003. Epub 2008 Jul 11.

PMID:
18620780
[PubMed - indexed for MEDLINE]
18.

Co-expression of PDGF-B and VEGFR-3 strongly correlates with lymph node metastasis and poor survival in non-small-cell lung cancer.

Donnem T, Al-Saad S, Al-Shibli K, Busund LT, Bremnes RM.

Ann Oncol. 2010 Feb;21(2):223-31. doi: 10.1093/annonc/mdp296. Epub 2009 Jul 23.

PMID:
19628565
[PubMed - indexed for MEDLINE]
Free Article
19.

Aberrant methylation of H-cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma.

Kim JS, Han J, Shim YM, Park J, Kim DH.

Cancer. 2005 Nov 1;104(9):1825-33. Review.

PMID:
16177988
[PubMed - indexed for MEDLINE]
Free Article
20.

Overexpression of Pin1 in non-small cell lung cancer (NSCLC) and its correlation with lymph node metastases.

He J, Zhou F, Shao K, Hang J, Wang H, Rayburn E, Xiao ZX, Lee SW, Xue Q, Feng XL, Shi SS, Zhang CY, Zhang S.

Lung Cancer. 2007 Apr;56(1):51-8. Epub 2007 Feb 2.

PMID:
17275947
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk